跳至主要内容
临床试验/CTRI/2026/01/100054
CTRI/2026/01/100054尚未招募不适用

Cross-sectional observational multicentre pan India real-world study in patients living with T2DM to understand the prevalence of key diabetes associated comorbidities and to analyze the characteristics of such patients (INSIGHTS)

Cipla Limited1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2026年1月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
Cipla Limited
入组人数
10,000
试验地点
1

研究概览

简要总结

The increasing burden of T2DM in India is closely linked with rising cases of comorbidities like ASCVD heart failure CKD and obesity all of which significantly influence clinical outcomes and management strategies Despite this limited real-world data exists on how these comorbidities manifest and co-exist in patients with T2DM in the Indian population There is a clear need to bridge this evidence gap through real-world studies that capture the prevalence and patient characteristics of these conditions Such insights can help enable more informed and personalized care approaches for Indian patients with T2DM

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
Male

入选标准

  • Patients more than or equal to 18 years of age Previously diagnosed with T2DM and under the treating doctor’s care for at least 3 months coming for follow-up and undergoing treatment Willing to provide written informed consent and comply with the study procedures.

排除标准

  • Patients with T1DM and/or Gestational diabetes mellitus Pregnant or lactating women or those planning pregnancy during the study period Participants in another clinical trial.

研究者

发起方
Cipla Limited
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Bipin Sethi

Cipla House

研究点 (1)

Loading locations...

相似试验